Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,4300.00,08/26/2015,GNRL,269532244
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3750.00,09/16/2014,GNRL,149200220
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3700.00,12/04/2014,GNRL,150117600
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3700.00,12/01/2014,GNRL,150407003
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3700.00,04/23/2014,GNRL,149960487
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3700.00,12/10/2015,GNRL,260078544
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3700.00,04/28/2015,GNRL,260101088
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250.00,02/12/2014,GNRL,150778134
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250.00,04/23/2014,GNRL,148427542
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250.00,10/26/2014,GNRL,150020590
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250.00,08/19/2014,GNRL,150908988
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250.00,01/06/2014,GNRL,148704442
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250.00,11/09/2014,GNRL,148424842
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250.00,10/12/2014,GNRL,149412497
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250.00,02/05/2015,GNRL,260103340
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2930.00,02/20/2015,GNRL,319078828
46454,GNRL,"Eli Lilly and Company",IN,100000000088,2817.00,11/04/2015,GNRL,267979960
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2800.00,09/18/2013,GNRL,221949840
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2800.00,12/11/2013,GNRL,221922120
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2800.00,03/14/2014,GNRL,160620900
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2800.00,11/13/2014,GNRL,160635562
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2800.00,10/16/2014,GNRL,160631834
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2800.00,11/18/2015,GNRL,269528040
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2800.00,09/17/2015,GNRL,269523872
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2800.00,08/07/2015,GNRL,269523890
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2800.00,11/11/2015,GNRL,269523908
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2630.00,09/30/2015,GNRL,318830802
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2550.00,10/11/2013,GNRL,221936742
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2460.00,12/15/2015,GNRL,319830994
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2300.00,10/07/2015,GNRL,318977008
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2300.00,09/24/2015,GNRL,319703960
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2300.00,04/29/2015,GNRL,319082892
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2300.00,06/22/2015,GNRL,318932775
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2300.00,09/18/2015,GNRL,318914534
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2290.26,11/17/2015,GNRL,319270266
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2290.00,04/17/2015,GNRL,318850187
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2260.00,03/15/2014,GNRL,188484646
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2130.00,12/18/2015,GNRL,319644434
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,10/22/2013,GNRL,221921362
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,08/09/2013,GNRL,221950290
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,12/06/2013,GNRL,221934494
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,10/17/2013,GNRL,221951634
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,11/14/2013,GNRL,221906138
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,11/25/2013,GNRL,221920204
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,03/14/2014,GNRL,160620936
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,09/09/2014,GNRL,160620932
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,12/02/2014,GNRL,160624754
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,02/08/2014,GNRL,160620918
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,10/30/2014,GNRL,160620922
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,11/18/2014,GNRL,160624758
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,06/20/2014,GNRL,160620904
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,03/07/2014,GNRL,160621076
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,07/29/2014,GNRL,160620924
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,12/12/2014,GNRL,160635558
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,04/24/2014,GNRL,160624750
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,04/09/2014,GNRL,160620908
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,06/27/2014,GNRL,160620928
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,04/17/2014,GNRL,160620916
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,07/16/2015,GNRL,269528032
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,09/16/2015,GNRL,269528036
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,09/28/2015,GNRL,269528044
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,12/18/2015,GNRL,269536440
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,10/06/2015,GNRL,269543926
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,12/03/2015,GNRL,269534306
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,10/28/2015,GNRL,269540062
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,10/30/2015,GNRL,269540256
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,10/29/2015,GNRL,269531560
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,02/25/2015,GNRL,269523856
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,11/25/2015,GNRL,269523860
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,10/19/2015,GNRL,269523868
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,03/04/2015,GNRL,269523874
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,04/27/2015,GNRL,269523878
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,09/25/2015,GNRL,269523886
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,06/09/2015,GNRL,269523894
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,06/10/2015,GNRL,269523898
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,02/25/2015,GNRL,269523904
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,02/18/2015,GNRL,269542440
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2050.00,12/16/2015,GNRL,269536188
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1970.00,11/10/2015,GNRL,319591043
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1910.00,03/28/2014,GNRL,188458104
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1850.00,10/12/2014,GNRL,148278422
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1850.00,12/14/2015,GNRL,260080462
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1850.00,04/12/2015,GNRL,260067516
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1850.00,02/05/2015,GNRL,260102812
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1805.00,09/21/2015,GNRL,319804312
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1805.00,04/21/2015,GNRL,319035036
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1760.00,05/28/2014,GNRL,188464892
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1700.00,02/24/2014,GNRL,148601656
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1640.00,10/07/2015,GNRL,319637294
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1640.00,06/24/2015,GNRL,318937100
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1640.00,04/21/2015,GNRL,319058394
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1595.00,08/06/2014,GNRL,194224304
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1500.00,11/13/2013,GNRL,14240843
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1500.00,08/07/2013,GNRL,221879798
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1500.00,09/18/2014,GNRL,160620912
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1500.00,12/03/2014,GNRL,160625928
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1500.00,07/21/2015,GNRL,269523864
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1500.00,09/21/2015,GNRL,269523882
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1500.00,12/21/2015,GNRL,269536880
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1470.00,12/18/2015,GNRL,319644452
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1400.00,11/06/2014,GNRL,148536478
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1400.00,10/12/2014,GNRL,149411740
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1400.00,10/07/2014,GNRL,150543426
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1400.00,11/26/2014,GNRL,148201894
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1400.00,02/05/2015,GNRL,260102862
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1300.00,11/20/2013,GNRL,13958780
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1300.00,10/30/2013,GNRL,13958782
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1300.00,12/13/2013,GNRL,13958781
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1300.00,04/10/2014,GNRL,148562628
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1300.00,02/19/2014,GNRL,149225828
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1300.00,03/05/2014,GNRL,149985138
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1300.00,03/26/2014,GNRL,149067368
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1300.00,04/22/2014,GNRL,149880890
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1300.00,01/22/2014,GNRL,187735020
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1284.18,10/20/2015,GNRL,290521584
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1250.00,11/12/2013,GNRL,103297068
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1200.00,12/11/2013,GNRL,221922114
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1189.80,02/20/2015,GNRL,319078886
46454,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,1150.00,05/16/2014,GNRL,194224236
46454,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,997.05,04/25/2014,GNRL,194224228
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,975.00,10/30/2013,GNRL,13958779
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,975.00,03/26/2014,GNRL,148635679
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,950.00,08/16/2013,GNRL,103297062
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,950.00,01/18/2015,GNRL,260099608
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,900.00,12/06/2013,GNRL,221922158
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,900.00,11/13/2014,GNRL,160626616
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,900.00,02/25/2015,GNRL,269523902
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,900.00,12/16/2015,GNRL,269536176
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,900.00,09/17/2015,GNRL,269543746
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,820.00,06/03/2015,GNRL,318484700
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,808.80,10/12/2013,GNRL,221936740
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,747.66,08/26/2015,GNRL,269535914
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,680.00,10/12/2013,GNRL,221936744
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,650.00,10/24/2013,GNRL,13958783
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,650.00,10/24/2013,GNRL,13958778
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,650.00,08/31/2015,GNRL,319627254
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,608.32,01/25/2014,GNRL,149613722
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,534.33,10/12/2013,GNRL,221935176
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,480.00,07/30/2014,GNRL,188466400
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,480.00,06/24/2014,GNRL,188465458
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,475.56,08/15/2014,GNRL,150783862
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,463.28,08/15/2014,GNRL,150328718
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,416.90,03/15/2014,GNRL,188451390
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,388.70,08/26/2015,GNRL,269535984
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,387.98,10/20/2015,GNRL,290140446
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,377.11,04/17/2015,GNRL,318850140
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,363.47,08/26/2015,GNRL,270208514
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,350.34,08/26/2015,GNRL,269536498
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,339.36,10/16/2014,GNRL,160631840
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,335.26,10/12/2013,GNRL,221936746
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,325.00,10/12/2013,GNRL,221936748
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,320.85,09/16/2015,GNRL,269523921
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,313.04,03/26/2014,GNRL,149811180
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,305.67,12/11/2013,GNRL,221922156
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,305.10,09/18/2013,GNRL,221949842
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,304.75,12/08/2015,GNRL,260116930
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,303.60,02/25/2015,GNRL,269524192
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,301.28,11/13/2014,GNRL,160635570
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,291.20,03/07/2014,GNRL,160621108
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,271.20,12/06/2013,GNRL,221922124
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,267.38,11/18/2015,GNRL,269523925
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,262.20,11/11/2015,GNRL,269524196
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,261.52,03/14/2014,GNRL,160621106
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,259.90,12/03/2015,GNRL,269534384
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,259.33,06/09/2015,GNRL,269524178
46454,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,250.00,08/27/2013,GNRL,103297070
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,250.00,10/29/2013,GNRL,14061167
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,250.00,12/18/2014,GNRL,150703386
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,250.00,11/10/2015,GNRL,260079746
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,250.00,10/19/2015,GNRL,260094502
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,238.05,12/16/2015,GNRL,269536452
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,237.80,02/20/2015,GNRL,319078872
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,235.75,08/07/2015,GNRL,269524174
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,233.07,04/17/2015,GNRL,318836754
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,213.88,01/22/2014,GNRL,187737228
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,207.58,02/25/2015,GNRL,269523932
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,207.57,09/30/2015,GNRL,318988865
46454,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,200.48,04/25/2014,GNRL,194224254
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,199.72,03/15/2014,GNRL,188484644
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,196.08,09/28/2015,GNRL,269523928
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,194.08,12/16/2015,GNRL,269535730
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,192.88,01/25/2014,GNRL,149790992
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,179.26,03/15/2014,GNRL,188451386
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,173.08,12/15/2015,GNRL,319186714
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,168.20,04/17/2015,GNRL,318850156
46454,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,165.09,04/26/2014,GNRL,194224244
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,163.92,04/17/2014,GNRL,160621090
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,163.87,10/07/2015,GNRL,319637314
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,163.85,10/30/2013,GNRL,13958793
46454,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,163.44,05/29/2014,GNRL,194224220
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,162.73,10/06/2015,GNRL,269543928
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,161.58,06/24/2015,GNRL,318930876
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,160.46,02/20/2015,GNRL,319078894
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,160.43,07/16/2015,GNRL,269523916
46454,GNRL,"Eli Lilly and Company",IN,100000000088,158.70,11/18/2015,GNRL,267979964
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,156.24,06/27/2014,GNRL,160621102
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,155.26,11/12/2014,GNRL,150627406
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,155.25,11/25/2015,GNRL,269523936
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,151.76,11/18/2014,GNRL,160624766
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,150.15,04/17/2015,GNRL,318850224
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,148.50,02/20/2015,GNRL,319078855
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,148.29,09/16/2015,GNRL,269523912
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,145.21,11/20/2013,GNRL,13958790
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,144.64,12/18/2013,GNRL,174051114
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,143.06,02/20/2015,GNRL,319090571
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,142.61,10/16/2014,GNRL,160631836
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,140.56,06/20/2014,GNRL,160621080
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,139.15,10/30/2015,GNRL,269540260
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,138.58,10/29/2015,GNRL,269531578
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,137.45,01/25/2014,GNRL,149800230
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,136.85,04/23/2015,GNRL,260065242
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,136.64,04/09/2014,GNRL,148380854
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,136.17,12/13/2013,GNRL,13958792
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,134.55,12/18/2015,GNRL,319823444
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,127.68,02/08/2014,GNRL,160621094
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,127.65,10/28/2015,GNRL,269540068
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,127.65,10/19/2015,GNRL,269524154
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,127.36,08/15/2014,GNRL,150867426
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,127.34,08/15/2014,GNRL,150787960
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,126.56,01/29/2014,GNRL,148504646
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,125.00,10/29/2015,GNRL,270196016
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,123.76,11/12/2014,GNRL,150189834
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,122.64,09/17/2014,GNRL,149606556
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,120.96,09/17/2014,GNRL,150917786
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,111.60,09/30/2015,GNRL,318988876
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,107.53,06/10/2015,GNRL,269524184
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,106.40,02/19/2014,GNRL,150721900
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,106.38,02/18/2015,GNRL,269542422
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,104.65,09/18/2015,GNRL,318967832
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,104.16,04/24/2014,GNRL,160624760
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,104.16,12/02/2014,GNRL,160624764
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,101.70,10/17/2013,GNRL,221951636
46454,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,101.25,04/25/2014,GNRL,194224260
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,100.00,08/31/2015,GNRL,260076104
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,100.00,11/11/2015,GNRL,270176345
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,100.00,02/25/2015,GNRL,270169474
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,100.00,10/06/2015,GNRL,270211486
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,99.87,09/16/2015,GNRL,270166688
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,99.00,11/13/2014,GNRL,162374934
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,98.90,09/24/2015,GNRL,319078675
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,98.39,04/17/2014,GNRL,162202204
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,97.75,11/14/2013,GNRL,221906140
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,97.75,12/06/2013,GNRL,221934386
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,97.67,04/09/2014,GNRL,149191208
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,96.60,04/29/2015,GNRL,319082907
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,96.32,01/22/2014,GNRL,187737248
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,95.56,03/26/2014,GNRL,148780114
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,95.23,01/25/2014,GNRL,149689666
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,95.20,03/05/2014,GNRL,150297852
46454,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,93.05,06/01/2015,GNRL,330907139
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,90.72,10/30/2014,GNRL,160621096
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,90.16,03/28/2014,GNRL,188413482
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,89.04,10/29/2014,GNRL,150608301
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,89.04,04/10/2014,GNRL,149058244
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,88.48,11/19/2014,GNRL,150267388
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,85.39,06/09/2015,GNRL,270153660
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,84.00,12/11/2013,GNRL,221922116
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,84.00,04/10/2014,GNRL,148745320
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,84.00,04/09/2014,GNRL,160621083
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,83.85,10/16/2014,GNRL,162393142
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,82.65,02/08/2014,GNRL,160809680
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,79.38,10/30/2013,GNRL,13958787
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,78.75,11/12/2014,GNRL,148644044
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,78.40,03/15/2014,GNRL,188451388
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,77.28,11/19/2014,GNRL,148187328
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,76.73,12/03/2014,GNRL,162287152
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,76.28,11/25/2013,GNRL,221920330
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,75.00,12/03/2015,GNRL,270206292
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,73.92,08/06/2014,GNRL,194224290
46454,GNRL,"AbbVie, Inc.",IL,100000000204,72.83,05/28/2015,GNRL,317428780
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,72.57,11/18/2014,GNRL,162310614
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,68.50,03/05/2014,GNRL,149810160
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,66.97,10/08/2014,GNRL,148434676
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,66.70,01/29/2015,GNRL,260116192
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,66.13,01/29/2015,GNRL,260115470
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,66.08,08/15/2014,GNRL,150746864
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,63.25,06/22/2015,GNRL,318932788
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,62.72,10/16/2014,GNRL,150037402
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,62.40,07/21/2015,GNRL,270175408
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,61.22,10/30/2014,GNRL,162182068
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,60.38,11/10/2015,GNRL,319591184
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,59.54,04/21/2015,GNRL,319058432
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,59.39,09/21/2015,GNRL,318920227
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,59.27,04/29/2015,GNRL,319069520
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,59.23,02/25/2015,GNRL,269524188
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,58.99,10/28/2015,GNRL,270188606
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,58.76,11/12/2013,GNRL,103297066
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,58.37,09/18/2014,GNRL,162049850
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,58.24,12/12/2014,GNRL,160635566
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,57.63,08/16/2013,GNRL,103297060
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,57.37,04/23/2015,GNRL,260066804
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,56.93,09/17/2015,GNRL,269543752
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,56.14,11/14/2013,GNRL,221905146
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,54.05,09/25/2015,GNRL,269524172
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,53.23,09/24/2015,GNRL,319078656
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,49.96,04/17/2015,GNRL,318850098
46454,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,49.12,11/11/2014,GNRL,198760666
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,47.60,06/24/2015,GNRL,318930834
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,47.35,04/22/2014,GNRL,148348280
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,46.63,04/07/2015,GNRL,260127984
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,44.60,08/15/2014,GNRL,149051792
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,44.46,08/15/2014,GNRL,148858528
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,44.00,04/17/2015,GNRL,318850117
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,43.15,08/15/2014,GNRL,150787516
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,43.15,08/15/2014,GNRL,150626144
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,42.56,01/25/2014,GNRL,149692030
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,40.12,10/30/2013,GNRL,13958791
46454,GNRL,"Eli Lilly and Company",IN,100000000088,40.00,11/18/2015,GNRL,267979966
46454,GNRL,"AbbVie, Inc.",IL,100000000204,40.00,01/22/2015,GNRL,317251674
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,39.95,10/21/2015,GNRL,290521578
46454,GNRL,"AbbVie, Inc.",IL,100000000204,39.04,09/24/2013,GNRL,104615880
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,38.89,09/18/2013,GNRL,221949686
46454,GNRL,"Dexcom, Inc.",CA,100000010478,38.84,06/03/2015,GNRL,334999944
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,38.21,01/25/2014,GNRL,149678664
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,38.08,10/16/2014,GNRL,150037280
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,38.08,07/29/2014,GNRL,160621100
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,37.95,04/27/2015,GNRL,269524164
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,37.29,08/09/2013,GNRL,221950292
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,36.16,10/22/2013,GNRL,221921366
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,36.12,10/17/2013,GNRL,221951632
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,34.99,10/21/2015,GNRL,290521606
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,32.46,06/13/2014,GNRL,161843874
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,32.12,12/22/2014,GNRL,196367320
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,31.50,02/03/2014,GNRL,160607028
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,31.00,02/20/2015,GNRL,319078818
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,30.95,10/07/2015,GNRL,318977074
46454,GNRL,"Valeritas, Inc.",NJ,100000010873,30.49,08/20/2015,GNRL,324695969
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,29.68,11/19/2014,GNRL,150268646
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,29.38,10/21/2015,GNRL,290521576
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,28.99,01/25/2014,GNRL,149174076
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,28.26,09/28/2015,GNRL,270170248
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,26.81,02/19/2015,GNRL,260037042
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,26.74,10/16/2014,GNRL,160632026
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,26.56,12/06/2013,GNRL,221934388
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,25.83,11/12/2013,GNRL,103297064
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,25.19,05/06/2015,GNRL,269934838
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,25.09,12/11/2013,GNRL,221922152
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,24.12,04/14/2015,GNRL,290521604
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,23.70,04/09/2014,GNRL,161138084
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,23.11,03/17/2015,GNRL,269636412
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,23.09,12/16/2013,GNRL,13958788
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,22.97,05/16/2014,GNRL,161391108
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,22.77,03/07/2014,GNRL,162173062
46454,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,22.22,02/06/2014,GNRL,216240952
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,21.85,12/06/2013,GNRL,221849542
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,21.37,06/23/2015,GNRL,269787972
46454,GNRL,"Eli Lilly and Company",IN,100000000088,21.30,11/18/2015,GNRL,267979968
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,21.00,10/22/2013,GNRL,221921358
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,20.92,08/15/2014,GNRL,150784116
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,20.92,08/15/2014,GNRL,150765130
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,20.92,08/15/2014,GNRL,150823608
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,20.86,04/22/2015,GNRL,319130361
46454,GNRL,"Eli Lilly and Company",IN,100000000088,20.85,11/18/2015,GNRL,267979962
46454,GNRL,"Eisai Inc.",NJ,100000000136,20.70,05/12/2014,GNRL,184465006
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.67,10/16/2014,GNRL,150176094
46454,GNRL,"Eisai Inc.",NJ,100000000136,19.67,03/03/2014,GNRL,184465012
46454,GNRL,"Medtronic MiniMed, Inc.",MN,100000010391,19.65,03/27/2014,GNRL,152104180
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.58,12/13/2013,GNRL,13958789
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,19.58,10/21/2015,GNRL,290521580
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,19.55,06/24/2014,GNRL,188687902
46454,GNRL,"Pfizer Inc.",NY,100000000286,19.49,08/26/2013,GNRL,206011940
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.36,10/30/2013,GNRL,13958786
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.28,09/10/2013,GNRL,13958785
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.67,11/10/2015,GNRL,290521588
46454,GNRL,"LILLY USA, LLC",IN,100000000066,18.65,08/21/2013,GNRL,100105802
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.50,06/16/2014,GNRL,148850374
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,18.05,12/06/2013,GNRL,221922122
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.03,04/10/2014,GNRL,148579228
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.94,02/19/2015,GNRL,269600208
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.80,04/30/2015,GNRL,260127634
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.73,12/12/2014,GNRL,162370236
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.70,06/09/2014,GNRL,161417720
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.66,02/04/2014,GNRL,160698420
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.53,03/31/2015,GNRL,269654540
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.24,01/25/2014,GNRL,149319745
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.24,11/06/2015,GNRL,270099896
46454,GNRL,"LifeScan, Inc.",PA,100000005709,16.95,08/08/2013,GNRL,10358069
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.91,07/01/2014,GNRL,161558982
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.89,08/07/2015,GNRL,270153610
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.66,12/08/2015,GNRL,270127978
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.63,01/09/2014,GNRL,194224269
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.63,04/13/2015,GNRL,269708584
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,16.61,11/10/2015,GNRL,319591073
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.55,06/05/2014,GNRL,196367318
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.48,04/16/2015,GNRL,336926464
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,16.47,09/23/2014,GNRL,188799382
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.35,08/19/2014,GNRL,161836023
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.32,03/26/2014,GNRL,148717248
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.22,12/16/2014,GNRL,150651100
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.15,03/12/2015,GNRL,260079946
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.11,11/24/2015,GNRL,270084094
46454,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,16.10,04/15/2015,GNRL,318823062
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,16.00,07/30/2014,GNRL,188816730
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,15.92,10/27/2015,GNRL,319440078
46454,GNRL,"Abbott Laboratories",IL,100000010680,15.44,08/29/2013,GNRL,102315302
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.44,01/08/2015,GNRL,290521602
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.27,03/05/2014,GNRL,160943184
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.22,10/16/2014,GNRL,149720344
46454,GNRL,"Pfizer Inc.",NY,100000000286,15.10,09/18/2014,GNRL,205990420
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,15.00,12/07/2015,GNRL,319727918
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.98,05/28/2015,GNRL,260113976
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,14.86,01/27/2014,GNRL,187744328
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.77,12/05/2014,GNRL,162399926
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.74,09/17/2014,GNRL,148391508
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.73,03/17/2014,GNRL,149556202
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.69,10/08/2014,GNRL,162317702
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.69,06/01/2015,GNRL,319515060
46454,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,14.67,07/14/2015,GNRL,333420064
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.58,12/17/2013,GNRL,221853289
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.55,08/06/2013,GNRL,103297054
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.49,11/18/2014,GNRL,196367316
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.42,07/29/2014,GNRL,161788212
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.39,06/03/2015,GNRL,319592219
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.34,06/27/2014,GNRL,161691052
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.29,02/19/2014,GNRL,150777852
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.28,08/15/2013,GNRL,14255503
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.28,06/09/2015,GNRL,290521596
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.25,11/19/2014,GNRL,148413178
46454,GNRL,"Lilly USA, LLC",IN,100000000066,14.15,06/11/2015,GNRL,267979952
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.13,09/15/2015,GNRL,290521590
46454,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,14.08,01/21/2015,GNRL,318823047
46454,GNRL,"LILLY USA, LLC",IN,100000000066,14.01,09/30/2014,GNRL,137867242
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.01,02/10/2015,GNRL,290521600
46454,GNRL,"LILLY USA, LLC",IN,100000000066,13.91,10/22/2013,GNRL,100014192
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.88,08/14/2014,GNRL,194224206
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.59,05/19/2015,GNRL,319545904
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.53,08/14/2014,GNRL,161882330
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.40,11/09/2015,GNRL,319429177
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.31,03/09/2015,GNRL,318499075
46454,GNRL,"EISAI INC.",NJ,100000000136,13.26,06/25/2015,GNRL,338008334
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.21,08/19/2014,GNRL,188816740
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.21,06/03/2014,GNRL,161634622
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.19,09/11/2013,GNRL,221887850
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.18,11/14/2013,GNRL,104378834
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.15,12/15/2014,GNRL,188869614
46454,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.14,08/05/2014,GNRL,198760662
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.00,01/16/2015,GNRL,269560900
46454,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.86,11/21/2013,GNRL,23817242
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.84,03/14/2014,GNRL,161213166
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.84,06/20/2014,GNRL,161576999
46454,GNRL,"Medtronic MiniMed, Inc.",MN,100000010391,12.78,05/20/2014,GNRL,152095830
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.77,12/21/2015,GNRL,270199646
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.76,09/03/2014,GNRL,162094124
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.68,05/07/2015,GNRL,269723892
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.67,09/01/2015,GNRL,318660648
46454,GNRL,"LILLY USA, LLC",IN,100000000066,12.65,03/27/2014,GNRL,137562754
46454,GNRL,"Eisai Inc.",NJ,100000000136,12.58,12/03/2013,GNRL,152462092
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.57,12/02/2014,GNRL,162217130
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.54,08/09/2013,GNRL,221950086
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.43,03/31/2015,GNRL,319656338
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.40,11/25/2015,GNRL,270172162
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.30,12/18/2015,GNRL,319823392
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.26,10/30/2015,GNRL,270191330
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.20,05/18/2015,GNRL,319463216
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.07,10/06/2014,GNRL,188878856
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.03,03/31/2014,GNRL,188557144
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.98,10/22/2015,GNRL,318941584
46454,GNRL,"LILLY USA, LLC",IN,100000000066,11.97,11/12/2013,GNRL,100167764
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.94,07/07/2015,GNRL,290521592
46454,GNRL,"VIVUS, Inc.",CA,100000005620,11.93,08/12/2013,GNRL,27276635
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.85,12/17/2015,GNRL,319799460
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.78,07/28/2014,GNRL,188708302
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.78,07/06/2015,GNRL,318607479
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.76,11/06/2014,GNRL,150766440
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.69,04/24/2014,GNRL,162217094
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.57,02/23/2015,GNRL,318687770
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.55,07/16/2015,GNRL,270166672
46454,GNRL,"EISAI INC.",NJ,100000000136,11.54,04/07/2015,GNRL,337946570
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.49,04/28/2015,GNRL,319065207
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.48,03/14/2014,GNRL,162044656
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.47,02/24/2015,GNRL,290521598
46454,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.46,12/19/2013,GNRL,13958784
46454,GNRL,"LILLY USA, LLC",IN,100000000066,11.46,11/25/2014,GNRL,137907254
46454,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,11.46,08/25/2015,GNRL,293468772
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.37,10/19/2015,GNRL,270153032
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.33,01/29/2015,GNRL,260120446
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.27,12/08/2015,GNRL,290521586
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.25,10/09/2015,GNRL,260117974
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.23,11/25/2013,GNRL,221920328
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.20,09/30/2013,GNRL,14263941
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.01,05/27/2014,GNRL,150873310
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.91,07/13/2015,GNRL,260099056
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.91,12/16/2015,GNRL,270199658
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.84,01/28/2014,GNRL,188636136
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.83,02/26/2015,GNRL,260105748
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.68,08/18/2015,GNRL,319125872
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.67,06/29/2015,GNRL,269791770
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.61,06/04/2014,GNRL,188705484
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.52,02/04/2015,GNRL,319255528
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.51,06/25/2015,GNRL,260114276
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.40,04/29/2014,GNRL,161305234
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.37,04/21/2015,GNRL,319035087
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.35,03/04/2015,GNRL,269524162
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.34,07/23/2015,GNRL,260031230
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.32,07/07/2014,GNRL,194224278
46454,GNRL,"Lilly USA, LLC",IN,100000000066,10.31,03/17/2015,GNRL,267979936
46454,GNRL,"Amgen Inc.",CA,100000000203,10.24,06/18/2015,GNRL,297596076
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.23,08/11/2014,GNRL,148320422
46454,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.13,02/18/2014,GNRL,156467782
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.11,02/25/2015,GNRL,270165826
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.07,06/22/2015,GNRL,318932857
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.78,12/21/2015,GNRL,269536646
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.78,09/22/2015,GNRL,319768172
46454,GNRL,"LifeScan, Inc.",PA,100000005709,9.74,10/23/2013,GNRL,10360313
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.63,09/25/2015,GNRL,270153604
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.61,09/17/2015,GNRL,270220216
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.58,05/28/2014,GNRL,188516420
46454,GNRL,"Lilly USA, LLC",IN,100000000066,9.54,01/26/2015,GNRL,267979942
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.53,09/24/2015,GNRL,318930664
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.47,06/23/2014,GNRL,188687900
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.45,07/28/2015,GNRL,269837938
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.42,10/27/2014,GNRL,188803648
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.36,02/05/2015,GNRL,319282561
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.09,08/06/2015,GNRL,319428110
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.05,03/28/2014,GNRL,188542000
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.85,02/12/2014,GNRL,160898388
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,8.83,01/13/2014,GNRL,150104990
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.79,04/06/2015,GNRL,319797081
46454,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.77,11/04/2014,GNRL,156467792
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.67,02/17/2015,GNRL,318785255
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,8.65,09/01/2015,GNRL,260120142
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.63,03/04/2015,GNRL,270153596
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.62,04/21/2015,GNRL,319035048
46454,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.49,09/04/2014,GNRL,156467784
46454,GNRL,"Lilly USA, LLC",IN,100000000066,8.38,08/26/2015,GNRL,267979954
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.27,08/05/2013,GNRL,14278801
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.18,09/17/2015,GNRL,270153070
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.09,09/24/2013,GNRL,221941096
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,8.03,01/29/2015,GNRL,260073134
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.96,11/18/2015,GNRL,270168490
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.64,11/04/2013,GNRL,221922788
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,7.26,05/19/2014,GNRL,188645848
46454,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.22,06/16/2015,GNRL,330604927
46454,GNRL,"Lilly USA, LLC",IN,100000000066,7.19,02/11/2015,GNRL,267979950
46454,GNRL,"Lilly USA, LLC",IN,100000000066,6.99,12/10/2015,GNRL,267979946
46454,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.89,05/05/2015,GNRL,330493077
46454,GNRL,"VIVUS, Inc.",CA,100000005620,6.81,10/14/2013,GNRL,27276638
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,6.72,11/13/2014,GNRL,160626620
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.67,09/18/2015,GNRL,318967848
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.63,01/20/2015,GNRL,319652120
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.83,08/16/2013,GNRL,103297058
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,5.78,04/17/2015,GNRL,318850204
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,5.04,09/29/2014,GNRL,149959352
46454,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.02,09/17/2014,GNRL,156467788
46454,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.02,10/10/2014,GNRL,156467790
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,4.97,10/08/2013,GNRL,103297056
46454,GNRL,"Lilly USA, LLC",IN,100000000066,4.84,12/10/2015,GNRL,267979944
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.51,02/20/2014,GNRL,160614608
46454,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,4.32,08/06/2014,GNRL,194224284
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.29,12/16/2015,GNRL,270187846
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,4.21,04/09/2014,GNRL,148583108
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.03,09/17/2015,GNRL,269524158
46454,GNRL,"Eli Lilly and Company",IN,100000000088,3.70,11/18/2015,GNRL,267979958
46454,GNRL,"AbbVie, Inc.",IL,100000000204,3.67,12/15/2015,GNRL,317009658
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.39,12/11/2013,GNRL,221922118
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.36,12/03/2014,GNRL,160625930
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.88,07/21/2015,GNRL,269524150
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.80,09/18/2014,GNRL,160621086
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2.51,04/06/2015,GNRL,319796994
46454,GNRL,"Lilly USA, LLC",IN,100000000066,2.49,12/10/2015,GNRL,267979948
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.30,09/21/2015,GNRL,269524168
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2.30,09/21/2015,GNRL,319804322
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2.25,06/24/2015,GNRL,318930864
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2.24,04/22/2014,GNRL,149051214
46454,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2.24,12/19/2014,GNRL,148453698
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.22,09/24/2013,GNRL,221941086
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.91,12/05/2013,GNRL,221849544
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.89,06/09/2014,GNRL,161417732
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.69,11/04/2013,GNRL,221922786
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1.50,12/15/2015,GNRL,319186698
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.48,11/10/2015,GNRL,290521582
46454,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.38,09/04/2014,GNRL,156467786
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.23,01/15/2015,GNRL,269560904
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.18,09/11/2013,GNRL,221887848
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.17,05/15/2014,GNRL,161391110
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1.09,09/24/2015,GNRL,318930633
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1.02,09/30/2013,GNRL,14263942
46454,GNRL,"LILLY USA, LLC",IN,100000000066,0.75,11/12/2013,GNRL,100167778
46454,GNRL,"Lilly USA, LLC",IN,100000000066,0.74,08/25/2015,GNRL,267979956
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.68,03/16/2015,GNRL,269636448
46454,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,0.64,07/07/2015,GNRL,290521594
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.56,08/13/2014,GNRL,161888500
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,0.54,04/06/2015,GNRL,319797032
46454,GNRL,"Lilly USA, LLC",IN,100000000066,0.53,03/17/2015,GNRL,267979938
46454,GNRL,"Lilly USA, LLC",IN,100000000066,0.49,01/26/2015,GNRL,267979940
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.47,12/05/2014,GNRL,162400586
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.33,06/30/2014,GNRL,162434954
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.28,07/28/2015,GNRL,269833298
46454,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,0.26,06/22/2015,GNRL,318932820
46454,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.18,08/18/2014,GNRL,161836012
